Abstract:The NAIP/NLRC4 inflammasome is classically associated with the detection of bacterial invasion to the cytosol. However, recent studies have demonstrated that NAIP/NLRC4 is also activated in non-bacterial infections, and in sterile inflammation. Moreover, in addition to the well-established model for the detection of bacterial proteins by NAIP proteins, the participation of other cytosolic pathways in the regulation of NAIP/NLRC4-mediated responses has been reported in distinct contexts. Using pharmacological inhibition and genetic deletion, we demonstrate here that cathepsins, well known for their involvement in NLRP3 activation, also regulate NAIP/NLRC4 responses to cytosolic flagellin in murine and human macrophages. In contrast to that observed for NLRP3 agonists, cathepsins inhibition did not reduce ASC speck formation or caspase-1 maturation in response to flagellin, ruling out their participation in the effector phase of NAIP/NLRC4 activation. Moreover, cathepsins had no impact on NF-κB-mediated priming of pro-IL-1β, thus suggesting these proteases act downstream of the NAIP/NLRC4 inflammasome activation. IL-1β levels secreted in response to flagellin were reduced in the absence of either cathepsins or Gasdermin-D (GSDMD), a molecule involved in the induction of pyroptosis and cytokines release. Notably, IL-1β secretion was abrogated in the absence of both GSDMD and cathepsins, demonstrating their non-redundant roles for the optimal IL-1β release in response to cytosolic flagellin. Given the central role of NAIP/NLRC4 inflammasomes in controlling infection and, also, induction of inflammatory pathologies, many efforts have been made to uncover novel molecules involved in their regulation. Thus, our findings bring together a relevant contribution by describing the role of cathepsins as players in the NAIP/NLRC4-mediated responses.

Localization and functionality of the inflammasome in neutrophils

The NLRP3/ASC/Caspase-1 axis regulates IL-1β processing in neutrophils

[Inflammasome and interleukin 1]

Cell type-specific roles of NLRP3, inflammasome-dependent and -independent, in host defense, sterile necroinflammation, tissue repair, and fibrosis

The Inflammasome NLRs in Immunity, Inflammation, and Associated Diseases

Inflammasome activation in neutrophils of patients with severe COVID-19

How location and cellular signaling combine to activate the NLRP3 inflammasome

Initiation and perpetuation of NLRP3 inflammasome activation and assembly

Activation and Pharmacological Regulation of Inflammasomes

Enigmatic inflammasomes

NLRP3, NLRP6, and NLRP12 are inflammasomes with distinct expression patterns

The NLRP3 inflammasome in health and disease: the good, the bad and the ugly

Recent Insights into the Regulatory Networks of NLRP3 Inflammasome Activation

Focus on the Role of NLRP3 Inflammasome in Diseases

The NLRP3 inflammasome: activation and regulation

The NLRP3 inflammasome: molecular activation and regulation to therapeutics

Neonatal neutrophils exhibit reduced NLRP3 inflammasome activation

The interplay between serine proteases and caspase-1 regulates the autophagy-mediated secretion of Interleukin-1 beta in human neutrophils

The NLRP3 Inflammasome: An Overview of Mechanisms of Activation and Regulation

Lysosomal cathepsins act in concert with Gasdermin-D during NAIP/NLRC4-dependent IL-1β secretion